CClinicalTrials.gg
Not yet recruitingNCT06160453HEROESUpdated Jul 17, 2024

HEROES: Human Extremity Robotic Rehabilitation and Outcome Enhancement for Stroke

An interventional study of Brain-Computer Interface control of robotic arms with augmented reality and Serious game with augmented reality in Stroke, sponsored by Aristotle University Of Thessaloniki. Not yet recruiting at 1 site in Greece. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-17.

Sponsored by Aristotle University Of Thessaloniki · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

HEROES is a multidisciplinary neurophysiological \& neural rehabilitation engineering project, developed by the Lab of Medical Physics \& Digital Innovation, School of Medicine, Faculty of Health Science Aristotle University of Thessaloniki and supported by a Neurosurgical Department. The website for the project can be accessed at https://heroes.med.auth.gr.

The investigation's primary objectives include the development, testing and optimization of an intervention based on multiple immersive man-machine interfaces offering rich feedback, that include a) mountable robotic arm controlled with wireless Brain-Computer Interface and b) wearable robotics jacket \& gloves in combination with a serious game application and c) augmented reality module for the presentation of the previous two, as well as the development and validation of a self-paced neuro-rehabilitation protocol for patients after chronic stroke with severe residual motor disability.

Read the detailed description

HEROES project's full title is \<Human Extremity Robotic Rehabilitation and Outcome Enhancement for Stroke>. It is a multidisciplinary neurophysiological \& neural rehabilitation engineering project, developed by the Lab of Medical Physics \& Digital Innovation, School of Medicine, Faculty of Health Science Aristotle University of Thessaloniki and supported by a Neurosurgical Department. The website for the project can be accessed at https://heroes.med.auth.gr .

The HEROES project involves:

  • A clinical study for rehabilitation of patients with Chronic Stroke (CS), using multiple immersive man-machine interfaces (Brain-Computer Interface (BCI) controlled robotic arms device, Wearable Robotics Jacket \& Gloves, Serious Gaming Application, Augmented Reality presentation)
  • A secondary off-line neurophysiological analysis of brain activation, connectivity and plasticity as well as muscle electrophysiology in patients with CS undergoing motor imagery (MI) and BCI training and assistance through electrical muscle stimulation

Milestones of the study:

  • The investigators aim to develop, test and optimize an intervention based on multiple immersive man-machine interfaces
  • The investigators aim to develop and validate self-paced neuro-rehabilitation protocols for patients with CS.
  • The investigators aim to identify and study the neurophysiological functionality and alteration of brain activity in chronic CS.

The brain neuron networks of Chronic Stroke (CS) patients and healthy individuals share similar connectivity patterns of, but new functional interactions have been identified as unique to CS patient networks and can be attributed to both adaptive and maladaptive organization effects after the stroke. The importance of such phenomena both as possible prognostic factors and as contributors to patient rehabilitation remains unspecified yet. The exact underlying neurophysiological process and the extent that this is modulated by higher-order interactions is also not fully understood. The investigators used rich visual and tactile feedback, virtual reality environments (VRE), BCI controlled exoskeleton and robotic actuators and furthermore documented plasticity effects at the brain networks.

Retraining brain circuits and promoting plasticity to restore body functions have been recognized among key principles of spinal cord repair by the US National Institute of Neurological Disorders and Stroke (US NIH/NINDS). Nonetheless, existing literature does not yet portray with precision the pathophysiological process and effect of CS on Central Nervous System (CNS) and the sensorimotor networks. Studies needed to address this issue (such as our study) should be considered, identifying specific questions to be answered through further investigation: a) how and why reorganization of CNS networks is established, b) how this reorganization evolves in time with respect to the severity and chronicity of the stroke, c) when can it be considered an adaptive or maladaptive evolution, and d) how can it be promoted or prevented respectively. The gained insight is expected to hold clinical relevance in preventing maladaptive plasticity after CS through individualized neuro-rehabilitation, as well as in the design of assistive technologies for CS patients.

This HEROES study is a both a pre-clinical neurophysiological investigation on human CS patients that aims to advance basic knowledge on CS sequelae to CNS and also a translational implementation in clinical (rehabilitation) practice. Our analysis aims to eventually help produce a model of CNS function along different stages of stroke (Acute, Sub-acute, Chronic), during different activity (resting state, simple motor tasks, complex sensorimotor activity), and ideally being able to predict negative outcome versus possible Recovery. The HEROES project aims to investigate and promote dormant neuroplasticity after chronic stroke, a type of injury that causes hemiparesis, hemiplegia, tetraparesis or tetraplegia. Our protocol will deploy training in brain computer interfaces and robotic arms, virtual environments (brain-controlled virtual arms, avatars and augmented reality wearable robotics with sensors and actuators (gloves \& jacket) and rich audio/visual/tactile stimuli along with serious gaming applications to enhance motivation. Visual and kinesthetic sensorimotor brain networks will also be studied using high density electroencephalography in order to demonstrate and monitor CNS plasticity.

This research project was supported by the Hellenic Foundation for Research and Innovation (H.F.R.I.) https://www.elidek.gr under the "2nd Call for H.F.R.I. Research Projects to support Faculty Members \& Researchers" (Project number: 4391).

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Chronic Stroke
  • Motor disability
  • Rehabilitation
  • Neuroplasticity
  • Robotics
  • Wearables
03

In context

Stroke

7,283 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's planned enrollment of 70 is above the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Aristotle University Of Thessaloniki is the lead sponsor of 274 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • At least 14 years of age
  • Female \& male stroke survivors and healthy individuals (age and gender matched)
  • Sufficient documentation of stroke in case of patients (clinical neurological examination, MRI)

Exclusion criteria

Exclusion Criteria:

  • Other neurological condition that has a possibility to significantly affect the neurological status of the participants (or) the ability to control a BCI (or) the neurophysiological recordings:
  • Traumatic brain injury
  • Central Nervous System tumors
  • Multiple Sclerosis
  • Amyotrophic Lateral Sclerosis
  • Parkinson's disease
  • Refractory Epilepsy
  • Other grave medical condition that could affect the participation (or) the safety of the participants:
  • Cardiac deficiency
  • Pulmonary deficiency
  • Hearing and visual impairments that can affect the participant's understanding of the --intervention and performance.
  • Illegal drug use
  • Chronic alcoholism
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Stroke with upper limb monoparesis or hemiparesis

    Patients from Greece, 18 y.o. or older, suffering from chronic stroke and motor disability

    Device: Brain-Computer Interface control of robotic arms with augmented reality · Device: Serious game with augmented reality

  • Experimental
    Stroke with monoplegia or hemiplegia

    Patients from Greece, 18 y.o. or older, suffering from chronic stroke and motor disability

    Device: Brain-Computer Interface control of robotic arms with augmented reality · Device: Serious game with augmented reality

  • Active comparator
    Healthy Participants

    Healthy participants, age and sex matched to the participants in the other arms

    Device: Brain-Computer Interface control of robotic arms with augmented reality · Device: Serious game with augmented reality

Interventions

  • DeviceBrain-Computer Interface control of robotic arms with augmented reality

    The participants will be trained to modulate self-paced Visual Motor Imagery (VMI) and Kinesthetic Motor Imagery (KMI) under EEG recording in order to achieve BCI-control of a custom-built bimanual arms robot (MERCURY v2.0). In KMI they will be asked to modulate brain waves in order to learn to control the BCI and in VMI they will additionally be projected a visual cue (representation of the intended movement). BCI will be used to control the arms in physical space as well as in an Augmented Reality Environment. Each participant will take part in 3 sessions

  • DeviceSerious game with augmented reality

    The participants will don wearable robotics and use them as input to play a dojo-themed immersive serious game intended at tracking participants movement and presenting them with motor tasks to perform. The game will be played in a computer screen, as well as in an Augmented Reality Environment. Each participant will take part in 10 sessions

06

What researchers measure

Primary outcomes

  1. BCI control

    The ability of participants to modulate brainwave activity in order to achieve control of the BCI will be established. BCI control is evaluated as achieved or not (there are cases of BCI-illiteracy when the participants cannot modulate their brainwaves in order to control the BCI).

    Time frame: 1 week

  2. Serious game performance (in-game scoring system)

    The ability of participants to control the wearables robotic jacket in order to complete in-game tasks and collect more points will be evaluated. The points will be gathered be matching the speed and position of the in-game task instructions while receiving assistance from electrical muscle stimulation.

    Time frame: 2 weeks

Secondary outcomes

  1. Initial Functional Improvement (Greek translation of the Modified Rankin Scale (mRS-9Q)

    Daily functionality as measured by the Greek translation of the Modified Rankin Scale (mRS-9Q). The scale ranges from 0 to 5, where 0 is the best.

    Time frame: 12 months

07

Study locations

1 site
  • Laboratory of Medical Physics and Digital Innovation, AUTH
    Thessaloniki, 54636, Greece
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized data will be made available after a Memorandum of Understanding agreement between the Medical Physics and Digital Innovation lab of Aristotle University of Thessaloniki and any interested party.

Supporting information: Study protocol, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06160453
Lead sponsor
Aristotle University Of Thessaloniki
Responsible party
Panos Bamidis (Professor, Aristotle University Of Thessaloniki) — Principal investigator
First posted
Dec 7, 2023
Start date
Dec 1, 2024 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jul 17, 2024

Study contacts

Alkinoos Athanasiou, PhD
Contact
athalkinoos@auth.gr
00302310999237
Panos D Bamidis, PhD
Contact
bamidis@auth.gr
00302310999237
Panos D Bamidis, PhD
principal investigator · Aristotle University Of Thessaloniki

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion